BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the company's common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarin's policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly.
Events & Presentations
Presentation at FDA Advisory Committee Meeting on Kyndrisa™ (drisapersen)
Nov 24, 2015 at 10:00 AM ET
Credit Suisse Healthcare Conference
Nov 11, 2015 at 9:30 AM MT